Jacobi Capital Management LLC Crinetics Pharmaceuticals, Inc. Transaction History

Jacobi Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$19.35 - $28.41 $29,025 - $42,615	-1,500 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$12.08 - $17.46 $18,120 - $26,190	-1,500 Reduced 50.0%	1,500 $21,000
Q2 2020 Aug 04, 2020	BUY	$13.04 - $23.23 $33,721 - $60,072	2,586 Added 624.64%	3,000 $53,000
Q2 2020 Jul 27, 2020	SELL	$13.04 - $23.23 $33,721 - $60,072	-2,586 Reduced 86.2%	414 $53,000
Q2 2019 Aug 07, 2019	BUY	$21.48 - $27.71 $64,440 - $83,130	3,000 New	3,000 $75,000

244

78.2M

268K

197K

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.73B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Jacobi Capital Management LLC with notifications on news.